Adetola A Kassim MD

Professor of Medicine, Vanderbilt University School of Medicine

Summary

Dr. Adetola Kassim is a hematologist based in Nashville, TN, with specialized training in hematology and medical oncology from Montefiore Medical Center/Albert Einstein College of Medicine. He completed his residency in internal medicine at the Icahn School of Medicine at Mount Sinai. Dr. Kassim has expertise in hematopoietic stem cell transplantation, plasma cell disorders, and sickle cell disease. His recent publications address various aspects of sickle cell disease, hematopoietic transplantation, and associated therapies. He has been involved in multiple clinical trials, including those focusing on bone marrow transplantation in sickle cell patients, the use of non-myeloablative conditioning, and treatments for multiple myeloma and hematologic cancers.

Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Fellowship, Hematology and Medical Oncology, 1996 - 1998
Icahn School of Medicine at Mount Sinai (North General)Residency, Internal Medicine, 1992 - 1995
University of Lagos College of MedicineClass of 1988

PubMed

1 citations
Nonselective β-Adrenergic Receptor Inhibitors Impair Hematopoietic Regeneration in Mice and Humans after Hematopoietic Cell Transplants.
Jinsuke Nishino, Wenhuo Hu, Ashwin Kishtagari, Bo Shen, Xiang Gao
Cancer Discovery. 2025-04-02
Feasibility of axicabtagene ciloleucel in the outpatient setting: primary analysis of prospective trial.
Bhagirathbhai Dholaria, Shakthi T Bhaskar, Vivek G Patel, Eden Biltibo, Reena Jayani
Bone Marrow Transplantation. 2025-03-24
Haploidentical Bone Marrow Transplantation for Sickle Cell Disease.
Adetola A Kassim, Mark C Walters, Mary Eapen, Madoc Smith, Brent R Logan
NEJM Evidence. 2025-03-01

Abstracts/Posters

Pozelimab, a Human Antibody Against Complement Factor C5, Demonstrates Robust Inhibition of Alternative Complement Activity Both in Normal Human Serum and in Phase I N...
Adetola A. Kassim, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Sickle Cell Disease Post-Transplant Care Challenges in Nigeria: Systematic Institutional Neglect of Medical Tourism
Adetola A. Kassim, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Venetoclax-Based Salvage Therapy for Post-Hematopoietic Cell Transplantation Relapse in Acute Myeloid Leukemia
Adetola A. Kassim, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Decline in Forced Expiratory Volume in 1 Second in Older Adults with Sickle Cell Disease Is Similar to Adults with Cystic Fibrosis
Adetola A. Kassim, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Primary Prevention of Strokes in Nigerian Children with Sickle Cell Disease (SPIN Trial): Final Results
Adetola A. Kassim, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Transfusion Support in Patients with Sickle Cell Anemia Undergoing Haploidentical Hematopoietic Cell Transplantation
Adetola A. Kassim, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Join now to see all

Fewer Side Effects with New Sickle Cell TreatmentApril 23rd, 2025
VUMC Part of New Study Validating Curative Therapy for Sickle Cell DiseaseFebruary 27th, 2025
Meet Michael DeBaun, MD, MPH – Maryville Board of TrusteesSeptember 15th, 2020
Join now to see all